InvestorsHub Logo

fred198484

02/20/17 10:38 AM

#11098 RE: BlueHorseshoe13 #11097

Are you aware of Ibalizumab? How do you think it will impact the prospects for PRO 140? It is going to be filed with the FDA soon (its phase III was completed in October of last year) and should be on the market later this year. Like PRO 140, it is a MAB and has no side-effects. It also treats all varieties of HIV (unlike PRO 140) and is given every two weeks via IV. Test results show it to be more effective that PRO 140 as well, although both drugs are pretty effective. PRO 140 is a good drug but it looks like a better drug will be on the market soon. Also, the financial situation of CYDY remains very precarious. How does PRO 140 survive the financial and competitive pressures?

misiu143

02/20/17 10:41 AM

#11099 RE: BlueHorseshoe13 #11097

BlueHorseshoe13- Thank you . I agree with every word in your post.

I really will like not to post very often , but it is hard when I see , IMO some posters misleading others.
I think they have a reason to repeat the same words like
" resistance", when fact say there is none so far, and many other not factual things.

But hopefully we will have soon even more positive things here .

I am leaving for a day, so have a good day , and lets hope for good tomorrow !!!